価格表

在庫・価格 : 2025年10月08日 07時49分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-Human CX3CL1/Fractalkine Affinity Purified Polyclonal Ab
データシート※最新のデータシートでない場合があります
AF365-SP RSDアールアンドディー システムズ
R&D Systems, Inc.
25 μg ¥27,000
(未発注)
追加

在庫・価格 : 2025年10月08日 07時49分 現在

Anti-Human CX3CL1/Fractalkine Affinity Purified Polyclonal Ab

  • 商品コード:AF365-SP
  • メーカー:RSD
  • 包装:25μg
  • 価格: ¥27,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Avril M et al. Interplay of Plasmodium falciparum and thrombin in brain endothelial barrier disruption. Sci Rep 2019 09;9(1):13142
Avril M et al
2019/01/01
Species: Human, Applications: Flow Cytometry PubMed
2 Erreni M et al. The Fractalkine-Receptor Axis Improves Human Colorectal Cancer Prognosis by Limiting Tumor Metastatic Dissemination. J. Immunol. 2016 Jan;196(2):902-14
Erreni M et al
2016/01/01
Species: Human, Applications: IHC-P PubMed
3 Tole S et al. Thromboxane prostanoid receptor stimulation induces shedding of the transmembrane chemokine CX3CL1 yet enhances CX3CL1-dependent leukocyte adhesion. Am. J. Physiol., Cell Physiol. 2010 Jun;298(6):C1469-80
Tole S et al
2010/01/01
Species: Human, Applications: Western Blot PubMed
4 Brissot E et al. Involvement of the CX3CL1 (fractalkine)/CX3CR1 pathway in the pathogenesis of acute graft-versus-host disease. J. Leukoc. Biol. 2015 Feb;97(2):227-35
Brissot E et al
2015/01/01
Species: Human, Applications: IHC-P PubMed
5 Zanchi C et al. Fractalkine and CX3CR1 mediate leukocyte capture by endothelium in response to Shiga toxin. J. Immunol. 2008 Jul;181(2):1460-9
Zanchi C et al
2008/01/01
Species: Human, Applications: Western Blot PubMed
6 Jamieson WL et al. CX3CR1 is expressed by prostate epithelial cells and androgens regulate the levels of CX3CL1/fractalkine in the bone marrow: potential role in prostate cancer bone tropism. Cancer Res. 2008 Mar;68(6):1715-22
Jamieson WL et al
2008/01/01
Species: Human, Applications: IHC-P PubMed
7 Nonn O et al. Placental CX3CL1 is Deregulated by Angiotensin II and Contributes to a Pro-Inflammatory Trophoblast-Monocyte Interaction. Int J Mol Sci 2019 Feb;20(3)
Nonn O et al
2019/01/01
Species: Human, Applications: Western Blot PubMed
8 Kassianos AJ et al. Fractalkine-CX3CR1-dependent recruitment and retention of human CD1c+ myeloid dendritic cells by in vitro-activated proximal tubular epithelial cells. Kidney Int. 2015 Jun;87(6):1153-63
Kassianos AJ et al
2015/01/01
Species: Human, Applications: IHC-Fr PubMed
9 Lucas AD et al. The transmembrane form of the CX3CL1 chemokine fractalkine is expressed predominantly by epithelial cells in vivo. Am. J. Pathol. 2001 Mar;158(3):855-66
Lucas AD et al
2001/01/01
Species: Human, Applications: Western Blot PubMed
10 Dorgham K et al. An engineered CX3CR1 antagonist endowed with anti-inflammatory activity. J. Leukoc. Biol. 2009 Oct;86(4):903-11
Dorgham K et al
2009/01/01
Species: Human, Applications: ELISA Development PubMed
11 Wang Y et al. Crosstalk between monocytes and renal mesangial cells via interaction of metalloproteinases and fractalkine in diabetic nephropathy. Mol Med Rep 2013 Dec;8(6):1817-23
Wang Y et al
2013/01/01
Species: Human, Applications: Western Blot PubMed
12 Zhang Q et al. Detection of fractalkine in human seminal plasma and its role in infertile patients. Hum. Reprod. 2002 Jun;17(6):1560-4
Zhang Q et al
2002/01/01
Species: Human, Applications: Western Blot PubMed
13 Latchney LR et al. Immunohistochemical assessment of fractalkine, inflammatory cells, and human herpesvirus 7 in human salivary glands. J. Histochem. Cytochem. 2004 May;52(5):671-81
Latchney LR et al
2004/01/01
Species: Human, Applications: IHC-P PubMed
14 Sarkar SA et al. Expression and regulation of chemokines in murine and human type 1 diabetes. Diabetes 2012 Feb;61(2):436-46
Sarkar SA et al
2012/01/01
Species: Human, Applications: Flow Cytometry PubMed
15 Huang YW et al. Constitutive endocytosis of the chemokine CX3CL1 prevents its degradation by cell surface metalloproteases. J. Biol. Chem. 2009 Oct;284(43):29644-53
Huang YW et al
2009/01/01
Species: Human, Applications: ICC PubMed
16 Shah R et al. Fractalkine is a novel human adipochemokine associated with type 2 diabetes. Diabetes 2011 May;60(5):1512-8
Shah R et al
2011/01/01
Species: Human, Applications: Neutralization PubMed
17 Ren T et al. Down-regulation of surface fractalkine by RNA interference in B16 melanoma reduced tumor growth in mice. Biochem. Biophys. Res. Commun. 2007 Dec;364(4):978-84
Ren T et al
2007/01/01
Species: Human, Applications: IHC-P PubMed
18 Bolovan-Fritts CA et al. Human cytomegalovirus-specific CD4+-T-cell cytokine response induces fractalkine in endothelial cells. J. Virol. 2004 Dec;78(23):13173-81
Bolovan-Fritts CA et al
2004/01/01
Species: Human, Applications: Western Blot PubMed
19 You JJ et al. Fractalkine, a CX3C chemokine, as a mediator of ocular angiogenesis. Invest. Ophthalmol. Vis. Sci. 2007 Nov;48(11):5290-8
You JJ et al
2007/01/01
Species: Bovine, Applications: Neutralization PubMed
  • No.: 1
  • 文献情報:
    Avril M et al. Interplay of Plasmodium falciparum and thrombin in brain endothelial barrier disruption. Sci Rep 2019 09;9(1):13142
    Avril M et al
    2019/01/01
  • 備考:
    Species: Human, Applications: Flow Cytometry
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Erreni M et al. The Fractalkine-Receptor Axis Improves Human Colorectal Cancer Prognosis by Limiting Tumor Metastatic Dissemination. J. Immunol. 2016 Jan;196(2):902-14
    Erreni M et al
    2016/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Tole S et al. Thromboxane prostanoid receptor stimulation induces shedding of the transmembrane chemokine CX3CL1 yet enhances CX3CL1-dependent leukocyte adhesion. Am. J. Physiol., Cell Physiol. 2010 Jun;298(6):C1469-80
    Tole S et al
    2010/01/01
  • 備考:
    Species: Human, Applications: Western Blot
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Brissot E et al. Involvement of the CX3CL1 (fractalkine)/CX3CR1 pathway in the pathogenesis of acute graft-versus-host disease. J. Leukoc. Biol. 2015 Feb;97(2):227-35
    Brissot E et al
    2015/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Zanchi C et al. Fractalkine and CX3CR1 mediate leukocyte capture by endothelium in response to Shiga toxin. J. Immunol. 2008 Jul;181(2):1460-9
    Zanchi C et al
    2008/01/01
  • 備考:
    Species: Human, Applications: Western Blot
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Jamieson WL et al. CX3CR1 is expressed by prostate epithelial cells and androgens regulate the levels of CX3CL1/fractalkine in the bone marrow: potential role in prostate cancer bone tropism. Cancer Res. 2008 Mar;68(6):1715-22
    Jamieson WL et al
    2008/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Nonn O et al. Placental CX3CL1 is Deregulated by Angiotensin II and Contributes to a Pro-Inflammatory Trophoblast-Monocyte Interaction. Int J Mol Sci 2019 Feb;20(3)
    Nonn O et al
    2019/01/01
  • 備考:
    Species: Human, Applications: Western Blot
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Kassianos AJ et al. Fractalkine-CX3CR1-dependent recruitment and retention of human CD1c+ myeloid dendritic cells by in vitro-activated proximal tubular epithelial cells. Kidney Int. 2015 Jun;87(6):1153-63
    Kassianos AJ et al
    2015/01/01
  • 備考:
    Species: Human, Applications: IHC-Fr
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Lucas AD et al. The transmembrane form of the CX3CL1 chemokine fractalkine is expressed predominantly by epithelial cells in vivo. Am. J. Pathol. 2001 Mar;158(3):855-66
    Lucas AD et al
    2001/01/01
  • 備考:
    Species: Human, Applications: Western Blot
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Dorgham K et al. An engineered CX3CR1 antagonist endowed with anti-inflammatory activity. J. Leukoc. Biol. 2009 Oct;86(4):903-11
    Dorgham K et al
    2009/01/01
  • 備考:
    Species: Human, Applications: ELISA Development
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Wang Y et al. Crosstalk between monocytes and renal mesangial cells via interaction of metalloproteinases and fractalkine in diabetic nephropathy. Mol Med Rep 2013 Dec;8(6):1817-23
    Wang Y et al
    2013/01/01
  • 備考:
    Species: Human, Applications: Western Blot
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Zhang Q et al. Detection of fractalkine in human seminal plasma and its role in infertile patients. Hum. Reprod. 2002 Jun;17(6):1560-4
    Zhang Q et al
    2002/01/01
  • 備考:
    Species: Human, Applications: Western Blot
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Latchney LR et al. Immunohistochemical assessment of fractalkine, inflammatory cells, and human herpesvirus 7 in human salivary glands. J. Histochem. Cytochem. 2004 May;52(5):671-81
    Latchney LR et al
    2004/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Sarkar SA et al. Expression and regulation of chemokines in murine and human type 1 diabetes. Diabetes 2012 Feb;61(2):436-46
    Sarkar SA et al
    2012/01/01
  • 備考:
    Species: Human, Applications: Flow Cytometry
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Huang YW et al. Constitutive endocytosis of the chemokine CX3CL1 prevents its degradation by cell surface metalloproteases. J. Biol. Chem. 2009 Oct;284(43):29644-53
    Huang YW et al
    2009/01/01
  • 備考:
    Species: Human, Applications: ICC
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Shah R et al. Fractalkine is a novel human adipochemokine associated with type 2 diabetes. Diabetes 2011 May;60(5):1512-8
    Shah R et al
    2011/01/01
  • 備考:
    Species: Human, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Ren T et al. Down-regulation of surface fractalkine by RNA interference in B16 melanoma reduced tumor growth in mice. Biochem. Biophys. Res. Commun. 2007 Dec;364(4):978-84
    Ren T et al
    2007/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Bolovan-Fritts CA et al. Human cytomegalovirus-specific CD4+-T-cell cytokine response induces fractalkine in endothelial cells. J. Virol. 2004 Dec;78(23):13173-81
    Bolovan-Fritts CA et al
    2004/01/01
  • 備考:
    Species: Human, Applications: Western Blot
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    You JJ et al. Fractalkine, a CX3C chemokine, as a mediator of ocular angiogenesis. Invest. Ophthalmol. Vis. Sci. 2007 Nov;48(11):5290-8
    You JJ et al
    2007/01/01
  • 備考:
    Species: Bovine, Applications: Neutralization
  • 参照:
    PubMed